Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
12 studies found for:    Open Studies | "Blood Donors"
Show Display Options
Rank Status Study
1 Recruiting Bone Density in Voluntary Apheresis Blood Donors
Condition: Bone Density
Intervention: Procedure: high frequency voluntary apheresis blood donation
2 Recruiting Recruiting Blood Donor With Allogeneic Natural Killer Cell
Condition: Healthy Volunteers
Intervention: Other: Leukapheresis or Plasmapheresis
3 Recruiting Zika Virus and Related Arbovirus Infections in Deferred Blood Donors (ZVADD)
Conditions: Zika Virus;   Dengue Virus;   Chikungunya Virus Infections
Intervention:
4 Recruiting A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by Infusions to Iron-deficient Blood Donors
Condition: Iron-deficiency
Interventions: Drug: Iron isomaltoside 1000 (Monofer®);   Drug: Placebo
5 Recruiting Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use
Conditions: Blood Donors;   Research Subjects;   Apheresis
Intervention:
6 Recruiting Hypercoagulation Screening in Cancer
Conditions: Healthy Blood Donors;   Moli-sani Subjects;   Cancer Patients
Intervention:
7 Recruiting Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection
Condition: Hepatitis C
Intervention:
8 Available Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants
Conditions: Hematologic Malignancies;   Inborn Errors of Metabolism Disorders;   Immune Deficiencies
Intervention: Biological: CliniMACS CD34 Reagent System
9 Recruiting Improving White Blood Cell Collection From Healthy Donors
Conditions: Blood Donor;   Leukocyte Transfusion;   Granulocyte Colony-Stimulation Factor;   Blood Component Removal
Interventions: Drug: Filgrastim (G-CSF);   Drug: Dexamethasone
10 Recruiting Collection of Bone Marrow From Healthy Volunteers and Patients for the Production of Clinical Bone Marrow Stromal Cell (BMSC) Products
Conditions: Bone Marrow;   Bone Marrow Stromal Cells;   Mesenchymal Stem Cells;   Blood Donors
Intervention:
11 Recruiting Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients
Conditions: Acute Leukemia;   Chronic Lymphocytic Leukemia;   Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Diffuse Large B-Cell Lymphoma;   Follicular Lymphoma;   Graft Versus Host Disease;   Mantle Cell Lymphoma;   Marginal Zone Lymphoma;   Myelodysplastic Syndrome;   Myelofibrosis;   Myeloproliferative Neoplasm;   Small Lymphocytic Lymphoma
Interventions: Biological: Thymoglobulin;   Drug: Bortezomib;   Drug: Tacrolimus
12 Recruiting Study of Transfusion-Transmitted Infections
Condition: Virus Disease
Intervention:

Study has passed its completion date and status has not been verified in more than two years.